Sfoglia per Autore "Vasileiou C., Befani C., Dimas K., Liakos P., Papandreou C."
Items 1-1 di 1
-
FGF-2 and HGF reverse abiraterone’s effect οn intracellular levels of DHT in androgen-dependent and androgen independent prostate cancer cell lines
Vasileiou C., Befani C., Dimas K., Liakos P., Papandreou C. (2020)Purpose: Growth factors such as fibroblast growth factor 2 (FGF-2) and hepatocyte growth factor (HGF) appear at high levels in prostate cancer (PC). Abiraterone is an androgen biosynthesis inhibitor which is currently in ...